Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Allergan plcAGN · Entity 149298 | Director | December 31, 2017 | February 14, 2018 |
| RESMED INCRMD · Entity 2692 | Director | November 20, 2025 | November 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Allergan plc
Report date December 31, 2017 · Filed February 14, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value $0.0001SEC Table I · non-derivative | Direct | 24,584 |
Reported balance
After 2017-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-06-16 · Gift · Disposed 721 · Balance 24,584 F1: Shares gifted to the Reporting Person's Ronald R. Taylor Trust. F2: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. |
| Ordinary Shares, par value $0.0001SEC Table I · non-derivative | IndirectRonald R. Taylor Trust | 721 |
Reported balance
Holding disclosure · report date 2017-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 721 F1: Shares gifted to the Reporting Person's Ronald R. Taylor Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares gifted to the Reporting Person's Ronald R. Taylor Trust.
F2: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
RESMED INC
Report date November 20, 2025 · Filed November 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 24,771 |
Reported balance
After 2025-11-20 transaction · row 1
1 source rowRow 1 · 2025-11-20 · Grant · Acquired 1,073 · Balance 24,771 F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2025 Filed Nov 24, 2025 15:49 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-25-000172 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,771 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:26 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027906 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,698 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:45 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-028038 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,615 F1 · shares: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2024, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 23:11 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026078 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2023, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 23:39 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 956 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-21-000033 · primary_doc.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,725 F1 · shares: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2022, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 16:48 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 4,000 | $200.14 | $800,564.40 |
DisclosureSEC source: 0001127602-21-006887 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,769 F1 · price: This transaction was executed in multiple trades at prices ranging from $200.07 to $200.50. The price reported above reflects the weighted average sale price. Read SEC document |
| November 19, 2020 Filed Nov 21, 2020 01:14 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-029774 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,769 F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 21:47 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033684 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,582 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2020, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 17:37 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 4,429 | $136.34 | $603,863.15 |
DisclosureSEC source: 0001127602-19-027155 · form4.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,855 F1 · price: This transaction was executed in multiple trades at prices ranging from $136.32 to $136.43. The price reported above reflects the weighted average sale price. Read SEC document |
| November 14, 2018 Filed Nov 17, 2018 00:28 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-006567 · doc1.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,284 F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2019, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:53 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 4,885 | $99.71 | $487,083.35 |
DisclosureSEC source: 0001140361-18-003152 · doc1.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,751 F1 · price: This transaction was executed in multiple trades at prices ranging from $99.43 to $99.90. The price reported above reflects the weighted average sale price. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 19:03 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-043348 · doc1.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,636 F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2018, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| June 16, 2017 Filed Feb 14, 2018 18:22 UTC | Allergan plc AGN · Entity 149298 | GiftOrdinary Shares, par value $0.0001 | 721 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002126 · edgar.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,584 F1 · shares: Shares gifted to the Reporting Person's Ronald R. Taylor Trust. F2 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| May 04, 2017 Filed May 5, 2017 18:24 UTC | Allergan plc AGN · Entity 149298 | GrantOrdinary Shares, par value $0.0001 | 1,223 | $245.25 | $299,940.75 |
DisclosureSEC source: 0001179110-17-006731 · edgar.xml · nonDerivative · entry 2 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,305 F2 · shares: These restricted stock units shall vest 100% on the earlier of (i) the day before the 2018 Annual General Meeting of Shareholders or (ii) May 4, 2018. F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| May 03, 2017 Filed May 5, 2017 18:24 UTC | Allergan plc AGN · Entity 149298 | Tax withholdingOrdinary Shares, par value $0.0001 | 668 | $243.76 | $162,831.68 |
DisclosureSEC source: 0001179110-17-006731 · edgar.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,082 F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 02:19 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 4,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087151 · doc1.xml · nonDerivative · entry 1 TAYLOR RONALD R · CIK 0001161920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,645 F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2017, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.